Read More Pharma Industry News iOncologi to acquire TargImmune to expand RNA-based immunotherapy for solid tumors iOncologi, Inc., a clinical-stage biopharmaceutical company focused on immunotherapy, has announced the acquisition of TargImmune Therapeutics, a biotechnology… byPallavi MadhirajuMarch 17, 2025